U.S. Markets open in 6 hrs 42 mins

Pfizer exceeds Street expectations and divulges plan for tax law windfall

Angelica LaVito
Getty Images. Pfizer's guidance is higher than the Street's for the full year.

Pfizer on Tuesday beat the Street's fourth-quarter earnings expectations and laid out its plans for the new tax law.The pharmaceutical giant reported adjusted earnings per share of 62 cents. The Street had expected earnings per share of 56 cents. Revenue on $13.7 billion was in line with expectations.Pfizer's innovative health unit grew 5 percent on an operational basis from a year earlier, reaching $8.2 billion in revenue driven by Eliquis, Xeljanz and Prevenar. Its essential health business decreased 8 percent operationally year over year, falling to $5.4 billion.

Shares of Pfizer fell 1.6 percent in premarket trading after initially gaining. Meanwhile, Amazon

(NASDAQ: AMZN)

, Berkshire Hathaway

(NYSE: BRK.A)

and JPMorgan Chase

(NYSE: JPM)

announced

they would partner

on U.S. employee health care.

Here's how Pfizer did compared with what Wall Street expected:EPS: 62 cents

vs. the

Thomson Reuters estimate of 56 cents.Revenue: $13.7 billion vs. $13.7billion expected by Thomson Reuters' survey of analysts.In the fourth quarter, the company reported a net profit of $12.3 billion, or $2.02 per share. However, after stripping out special items, the company earned $3.8 billion, or 62 cents per share, in the latest period, outpacing analyst estimates of 56 cents per share.For the full year, Pfizer forecasts revenue ranging $53.5 billion to $55.5 billion and adjusted earnings per share ranging $2.90 to $3, above the Street's estimates of $53.9 billion and $2.78 per share, respectively. The guidance includes $5 billion in buybacks.Pfizer said its effective tax rate on adjusted income will be about 17 percent next year, down from 20 percent this year. It anticipates a $15 billion tax bill over eight years to repatriate its overseas cash.In wake of the new tax law, the company plans to invest approximately $5 billion in capital projects in the U.S., including building its manufacturing presence. It plans to contribute $500 million to its U.S. pension plan and has allocated about $100 million for a special, one-time bonus for all nonexecutive employees in the first quarter of 2018.Pfizer also contributed $200 million to the Pfizer Foundation.

Bids are due Thursday for its consumer health unit. The company expects the business, which includes brands like Advil and ChapStick, to generate about $20 billion. Johnson & Johnson

(NYSE: JNJ)dropped out of the competition

, leaving GlaxoSmithKline

(London Stock Exchange: GSK-GB)

and Reckitt Benckiser

(London Stock Exchange: RB.-GB)

among those preparing bids.

"We remain on track to make this decision, which could include everything from a full or partial separation to ultimately deciding to retain the business, during 2018," CEO Ian Read said in a statement.

Pfizer on Tuesday beat the Street's fourth-quarter earnings expectations and laid out its plans for the new tax law.

The pharmaceutical giant reported adjusted earnings per share of 62 cents. The Street had expected earnings per share of 56 cents. Revenue on $13.7 billion was in line with expectations.

Pfizer's innovative health unit grew 5 percent on an operational basis from a year earlier, reaching $8.2 billion in revenue driven by Eliquis, Xeljanz and Prevenar. Its essential health business decreased 8 percent operationally year over year, falling to $5.4 billion.

Shares of Pfizer fell 1.6 percent in premarket trading after initially gaining. Meanwhile, Amazon

(NASDAQ: AMZN)

, Berkshire Hathaway

(NYSE: BRK.A)

and JPMorgan Chase

(NYSE: JPM)

announced

they would partner

on U.S. employee health care.

Here's how Pfizer did compared with what Wall Street expected:

EPS: 62 cents

vs. the

Thomson Reuters estimate of 56 cents.

Revenue: $13.7 billion vs. $13.7

billion expected by Thomson Reuters' survey of analysts.

In the fourth quarter, the company reported a net profit of $12.3 billion, or $2.02 per share. However, after stripping out special items, the company earned $3.8 billion, or 62 cents per share, in the latest period, outpacing analyst estimates of 56 cents per share.

For the full year, Pfizer forecasts revenue ranging $53.5 billion to $55.5 billion and adjusted earnings per share ranging $2.90 to $3, above the Street's estimates of $53.9 billion and $2.78 per share, respectively. The guidance includes $5 billion in buybacks.

Pfizer said its effective tax rate on adjusted income will be about 17 percent next year, down from 20 percent this year. It anticipates a $15 billion tax bill over eight years to repatriate its overseas cash.

In wake of the new tax law, the company plans to invest approximately $5 billion in capital projects in the U.S., including building its manufacturing presence. It plans to contribute $500 million to its U.S. pension plan and has allocated about $100 million for a special, one-time bonus for all nonexecutive employees in the first quarter of 2018.

Pfizer also contributed $200 million to the Pfizer Foundation.

Bids are due Thursday for its consumer health unit. The company expects the business, which includes brands like Advil and ChapStick, to generate about $20 billion. Johnson & Johnson

(NYSE: JNJ)

dropped out of the competition

, leaving GlaxoSmithKline

(London Stock Exchange: GSK-GB)

and Reckitt Benckiser

(London Stock Exchange: RB.-GB)

among those preparing bids.

"We remain on track to make this decision, which could include everything from a full or partial separation to ultimately deciding to retain the business, during 2018," CEO Ian Read said in a statement.



More From CNBC

  • Finance
    CNBC

    Morgan Stanley: The stock sell-off is going to get worse

    The stock market is in the middle of a rolling bear market, says Morgan Stanley's Mike Wilson. "It's being caused by a drain in liquidity and peaking growth," Wilson says. The stock market sell-off is only going to get worse, predicts Morgan Stanley's chief U.S. equity strategist, Mike Wilson.

  • Why New Age Beverage Corp. Stock Popped Today
    Business
    Motley Fool

    Why New Age Beverage Corp. Stock Popped Today

    Shares of New Age Beverage Corp. (NASDAQ: NBEV) were climbing again today, riding a surge on marijuana stocks as growers like Tilray, Cronos Group, and Canopy Growth all jumped by double digits. Along with the bullish sentiment in the industry, a number of other factors seemed to be driving New Age shares higher, including the recent hiring of a new CFO, the upcoming legalization of recreational marijuana in Canada on Wednesday, and the market's reaction to its launch last week of a new line of beverages infused with cannabidiol (CBD). On Friday, New Age named Gregory Gould as its new CFO, a notable move as Gould brings experience from the pharmaceutical industry, which should help the beverage company as it moves into CBD products.

  • Sears bankruptcy could make these 5 big companies multi-million-dollar losers
    Finance
    Yahoo Finance

    Sears bankruptcy could make these 5 big companies multi-million-dollar losers

    Being an unsecured creditor of Sears (SHLD) right now is not a good place to be. The 125-year old former retail icon filed for chapter 11 bankruptcy protection early on Monday, crippled from years of losses and mounting debt. Sears plans to close about

  • Brits Are All Making the Same Joke About the New Royal Baby
    News
    Time

    Brits Are All Making the Same Joke About the New Royal Baby

    Meghan Markle, the Duchess of Sussex, is expecting her first child with Prince Harry. The news, announced Monday morning by Kensington Palace, has already been greeted by hundreds of messages of congratulations for the royal couple on social media. The U.K. is set to leave the European Union on March 29, exactly two years after Prime Minister Theresa May started the formal process for doing so by invoking Article 50 of the Lisbon Treaty.

  • Why Marijuana Stocks Canopy Growth, Cronos Group, and Tilray Crushed It Today
    Business
    Motley Fool

    Why Marijuana Stocks Canopy Growth, Cronos Group, and Tilray Crushed It Today

    The three Canadian marijuana stocks that currently trade on major U.S. stock exchanges enjoyed big gains on Monday. Shares of Canopy Growth (NYSE: CGC) were up 14% as of 3:48 p.m. EDT, while Cronos Group (NASDAQ: CRON) and Tilray (NASDAQ: TLRY) jumped 18.9% and 12.1%, respectively. Two of the three marijuana growers reported new developments earlier in the day.

  • These are the bad things about early retirement that no one talks about
    News
    MarketWatch

    These are the bad things about early retirement that no one talks about

    For all the glamour of living an early retirement lifestyle, there are plenty of negatives I’ve come to discover since I permanently left my job in 2012. As a result, you’re repeatedly forced to will yourself into action.

  • Elizabeth Warren Calls on Trump to Pay $1 Million After Releasing DNA Test
    Politics
    Fortune

    Elizabeth Warren Calls on Trump to Pay $1 Million After Releasing DNA Test

    Elizabeth Warren is ready for her pay day. The senator from Massachusetts took to Twitter Monday morning, calling on President Donald Trump to cough up the $1 million he promised if she proved she had Native American heritage.

  • As Cannabis D-Day Approaches, Winners and Losers Set to Emerge
    Business
    Bloomberg

    As Cannabis D-Day Approaches, Winners and Losers Set to Emerge

    After Canada legalizes recreational marijuana on Oct. 17, it will only take a quarter or two for clear winners and losers to emerge, according to investors and analysts who follow the sector. “These have all been concept stocks and they’re going to actually have to be real companies in another few months, which I think a lot of guys are terrified about,” said Greg Taylor, who manages the Purpose Marijuana Opportunities Fund. Taylor prefers CannTrust Holdings Inc., Hexo Corp. and Organigram Holdings Inc., which he says trade at a “more realistic valuation” than some of their bigger peers.

  • Jamal Khashoggi was accidentally killed during interrogation: report
    World
    Fox Business Videos

    Jamal Khashoggi was accidentally killed during interrogation: report

    Fox Business foreign policy analyst Walid Phares on the report that Saudi journalist Jamal Khashoggi was accidentally killed.

  • 2 Hot Marijuana Stocks Listing Soon on U.S. Exchanges -- Are They Buys?
    Business
    Motley Fool

    2 Hot Marijuana Stocks Listing Soon on U.S. Exchanges -- Are They Buys?

    Two marijuana stocks that are currently listed on Canadian stock exchanges soon plan also to list on U.S. stock exchanges. Aurora Cannabis (NASDAQOTH: ACBFF) (TSX: ACB) expects to trade on the New York Stock Exchange (NYSE) by the end of October and Aleafia Health (NASDAQOTH: ALEAF) should soon trade on the Nasdaq stock exchange. Are these hot marijuana stocks that are coming soon to U.S. stock exchanges smart picks to buy now?

  • After years of wasting time in meetings, 3 former Googlers decided to do things differently at their new startup
    Business
    Business Insider

    After years of wasting time in meetings, 3 former Googlers decided to do things differently at their new startup

    The executives of the startup Beeswax, all former Google execs, say they've learned how to keep meetings streamlined and efficient. The three founders of the ad-tech startup Beeswax seem to get that. "We're all thoughtful about not having a proliferation of meetings, because one thing we all felt in our previous careers is that there can be lots of redundant meetings," Shamim Samadi, Beeswax's chief product officer, told Business Insider.

  • Goldman Sachs and Raymond James cut Netflix price target ahead of earnings
    Business
    Yahoo Finance Video

    Goldman Sachs and Raymond James cut Netflix price target ahead of earnings

    Netflix getting its price target slashed by both Goldman Sachs and Raymond James ahead of its highly expected earnings report tomorrow. Both firms are concerned that rising interest rates could pinch the company’s valuation.

  • Finance
    TheStreet.com

    Monday Madness: Is Nvidia a Hit or Miss?

    TheStreet's Julie Iannuzzi covered Jim Cramer's investing boot camp. Nvidia (NVDA - Get Report) has long been a favorite of TheStreet's founder and Action Alerts Plus Portfolio Manager Jim Cramer, but he told a packed audience Saturday at his Boot Camp for Investors in New York why his charitable trust recently sold out of the stock.

  • Business
    TheStreet.com

    Canopy Growth Is Poised to Explode to the Upside

    Shares of Canopy have soared 68% over the past three months. In this daily bar chart of CGC, below, we can see that prices are up five-fold over the past 12 months. CGC was trading at $10 back last October and now is trading around $50 with spikes above $55 last month.

  • Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla
    Business
    MarketWatch

    Marijuana stocks to watch: Canopy Growth is the cannabis business’s $4 billion gorilla

    The following article is part of a package of stories that MarketWatch is publishing to mark the start of full legalization of cannabis for adult use in Canada on Wednesday. Smith Falls, Ontario–based Canopy Growth Corp. made headlines and drove cannabis stocks to new heights over the summer when it announced that Corona brewer Constellation Brands Inc. was going to invest an additional $4 billion in the company. Billed by both companies as a strategic partnership, the additional $4 billion investment adds to the 9.9% stake that Constellation bought in October of last year and sets the company up to either be bought outright by Constellation — via warrants that could increase its stake to more than 50% — or continue to work with the beverage company to create a range of consumer-focused cannabis products that may one day appear in markets in dozens of countries.

  • Saudi Arabia Breaks 45-Year Taboo With Veiled Threat to Use Oil as a Weapon
    World
    Bloomberg

    Saudi Arabia Breaks 45-Year Taboo With Veiled Threat to Use Oil as a Weapon

    While few think that Saudi Arabia is prepared to follow through, even the suggestion of using oil as a weapon undermines Riyadh’s long-standing effort to project itself as a force for economic stability. The anxieties were exacerbated by an opinion piece penned by Turki Al Dakhil, who heads the state-owned Arabiya news network and is close to the Royal Court, in which he openly talked about using oil as a weapon.

  • This Is the Average American's Salary. How Does Yours Compare?
    Business
    Motley Fool

    This Is the Average American's Salary. How Does Yours Compare?

    In an age of oversharing, many of us are remarkably tight-lipped when it comes to talking salary. But in reality, knowing where you stand can help you determine whether you're in a good place or whether you should be taking steps to boost your earnings

  • Many U.S. mall owners say good riddance to Sears
    Finance
    Reuters

    Many U.S. mall owners say good riddance to Sears

    The real estate investment trusts that own the malls and shopping centers where many Sears stores are anchor tenants have waited years for the retailer's demise to renovate the sites and boost rent, although redevelopment costs may strain some plans. Most large U.S. malls are controlled by REITs. In recent years, the REITs have cut their exposure to Sears Holdings Corp, which filed for Chapter 11 bankruptcy on Monday.

  • Warren Buffett predicted the fall of Eddie Lampert and Sears over 10 years ago (SHLD, BRK.A, BRK.B)
    Finance
    Business Insider

    Warren Buffett predicted the fall of Eddie Lampert and Sears over 10 years ago (SHLD, BRK.A, BRK.B)

    Sears filed for Chapter 11 bankruptcy early Monday, the culmination of a downward spiral. CEO Eddie Lampert, once called the "next Warren Buffett," will also step down. Incidentally, Buffett predicted the retailer's and Lampert's downfall in 2005.

  • Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group
    Business
    Motley Fool

    Better Marijuana Stock: Aurora Cannabis vs. Auxly Cannabis Group

    One is market cap: Aurora's market cap is nearly 18 times bigger than Auxly's. Then there's stock performance. Here's how Aurora Cannabis and Auxly Cannabis Group stack up against each other in the areas that do matter.

  • Why Marijuana Stocks Cronos Group, Canopy Growth, and Tilray Jumped Today
    Business
    Motley Fool

    Why Marijuana Stocks Cronos Group, Canopy Growth, and Tilray Jumped Today

    The stock market pulled back on Monday, with major benchmarks failing to build on the positive momentum from last Friday. Cronos Group (NASDAQ: CRON), Canopy Growth (NYSE: CGC), and Tilray (NASDAQ: TLRY) were among the best performers. All three of these stocks have something in common: They all stand to benefit from Wednesday's effective date for legal sales of recreational cannabis product in Canada.

  • Finance
    TheStreet.com

    General Electric Slips as Cowen Suggests Culp Needs to Take Action

    fell Monday after Cowen and Co. cut its price target on the stock as analysts expect the new Chief Executive Larry Culp to take actions to improve the beleaguered industrial's financial standing. Cowen analysts, including Gautam Khanna, said they expect Culp to impose a dividend cut, possibly raise more equity, and reset earnings per share/free cash flow, to shore up the balance sheet.

  • Here’s How Prince Harry and Meghan Markle’s Baby Will Change the Line Of Succession
    News
    Time

    Here’s How Prince Harry and Meghan Markle’s Baby Will Change the Line Of Succession

    Prince Harry and Meghan Markle are expecting a baby in spring 2019, Kensington Palace announced Monday morning. Harry and Meghan married in May, becoming the Duke and Duchess of Sussex. Now, the question is where the new arrival will fit into the line of succession of the British royal family.

  • Lands’ End shares sink after Sears bankruptcy announcement
    Business
    American City Business Journals

    Lands’ End shares sink after Sears bankruptcy announcement

    Shares of Lands’ End Inc. declined more than 4 percent Monday on the same day that its longtime retail partner Sears Holdings Corp. declared Chapter 11. Hoffman Estates, Illinois-based Sears (Nasdaq: SHLD) filed for bankruptcy protection on Monday and announced plans to close another 142 stores across the country. The closures, as well as the hundreds of stores that Sears has shuttered previously, impact Lands’ End because the Dodgeville-based casual apparel company operates Lands’ End shops at Sears stores across the shrinking chain.

  • The Worst Mistake Tilray Investors Can Make Right Now
    Business
    Motley Fool

    The Worst Mistake Tilray Investors Can Make Right Now

    Tilray (NASDAQ: TLRY) investors have certainly seen plenty of opportunities to mess up lately, especially with the stock experiencing huge swings both up and down on a frequent basis. When Tilray conducted its initial public offering (IPO) back in July 2018, the company immediately became the third-largest Canadian marijuana stock in terms of market cap. Although Canopy briefly regained its mantle as the marijuana stock with the greatest market cap, Tilray is again on top.